Table 1.
Baseline characteristics of the included ASPREE male participants.
| Characteristics | ASPREE |
|---|---|
| Participants | 5701 |
| Age at randomisation (mean (SD)) | 74.9 (4.2) |
| Age Group (%) | |
| 70–74 | 3566 (62.6) |
| 75–79 | 1384 (24.3) |
| 80–84 | 585 (10.3) |
| 85+ | 166 (2.9) |
| Current or former smoker (%) | 3203 (56.2) |
| Diabetes (%) | 637 (11.2) |
| Randomized to Aspirin (%) | 2837 (49.8) |
| Body-mass-index (kg/m2) − mean (SD) | 27.9 (3.8) |
| Current alcohol consumption (%) | 4880 (85.6) |
| Family history of prostate cancer (%) | 499 (8.8) |
| Polygenic Risk Score − mean (SD) | −0.46 (0.15) |
| Prevalent Prostate Cancer (%) (self-reported at enrolment) | |
| None | 4725 (88.5) |
| <49 years | 4 (0.0) |
| ≥50 years | 654 (11.5) |